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ABSTRACT
Objective Hypoxia affects body iron homeostasis;
however, the underlying mechanisms are incompletely
understood.
Design Using a standardised hypoxia chamber,
23 healthy volunteers were subjected to hypoxic
conditions, equivalent to an altitude of 5600 m, for 6 h.
Subsequent experiments were performed in C57BL/6
mice, CREB-H knockout mice, primary hepatocytes and
HepG2 cells.
Results Exposure of subjects to hypoxia resulted in a
signiﬁcant decrease of serum levels of the master
regulator of iron homeostasis hepcidin and elevated
concentrations of platelet derived growth factor (PDGF)-
BB. Using correlation analysis, we identiﬁed PDGF-BB to
be associated with hypoxia mediated hepcidin repression
in humans. We then exposed mice to hypoxia using a
standardised chamber and observed downregulation of
hepatic hepcidin mRNA expression that was paralleled
by elevated serum PDGF-BB protein concentrations and
higher serum iron levels as compared with mice housed
under normoxic conditions. PDGF-BB treatment in vitro
and in vivo resulted in suppression of both steady state
and BMP6 inducible hepcidin expression. Mechanistically,
PDGF-BB inhibits hepcidin transcription by downregulating
the protein expression of the transcription factors CREB
and CREB-H, and pharmacological blockade or genetic
ablation of these pathways abrogated the effects of
PDGF-BB toward hepcidin expression.
Conclusions Hypoxia decreases hepatic hepcidin
expression by a novel regulatory pathway exerted via
PDGF-BB, leading to increased availability of circulating
iron that can be used for erythropoiesis.
INTRODUCTION
Hypoxic stress commonly occurs as a consequence
of environmental or pathological disturbances
resulting in reduced oxygen tension in the blood or
in tissues.1 As compensation, the body tries to
expand the oxygen transport capacities as reﬂected
by a rapid increase in circulating erythropoietin
(EPO) levels and stimulation of erythropoiesis
during hypoxic stress.2 3 A prerequisite for efﬁcient
erythropoiesis is a sufﬁcient supply of iron that is
needed for the synthesis of haemoglobin.3 4 The
higher iron needs for erythropoiesis during hypoxic
challenge are met by mobilisation of the metal
from body iron stores and increased duodenal iron
absorption.5 6 It has been suggested that such adap-
tations of body iron homeostasis require regulation
of the master regulator of iron homeostasis, hepci-
din, a mainly liver derived 25-amino acid
peptide.7–9
Hepcidin controls iron metabolism by binding to
the only known cellular iron exporter ferroportin
(also known as SCL40A1or Ireg1), thereby indu-
cing its internalisation and degradation.
Accordingly, high circulating hepcidin levels—as
they are seen in transfusional iron overload or
inﬂammation—block duodenal iron absorption and
iron egress from macrophages/monocytes,9 10
Signiﬁcance of this study
What is already known on this subject?
▸ Vertebrates respond to hypoxia with
stimulation of erythropoiesis in order to
compensate for reduced oxygen tension. To
meet the increased need of iron for
haemoglobin synthesis under such stress
conditions, the central regulator of iron
metabolism, hepcidin, is massively suppressed.
However, the underlying mechanisms for
hepcidin suppression in hypoxia are still
elusive.
What are the new ﬁndings?
▸ We demonstrate that platelet derived growth
factor (PDGF)-BB is a main inhibitor of hepcidin
in hypoxia. Interestingly, PDGF-BB signalling
interferes with a recently described signalling
mechanism for hepcidin regulation. Notably, we
could show that recombinant PDGF-BB directly
inhibits hepcidin expression also in wild-type
mice.
How might it impact on clinical practice in
the foreseeable future?
▸ Currently, different antihepcidin strategies are
evaluated in preclinical and clinical studies for
the therapy of anaemia of chronic disease
(ACD), which is also found in IBD patients.
Therefore, recombinant PDGF-BB could be a
valuable new therapy for the treatment of ACD.
Sonnweber T, et al. Gut 2014;63:1951–1959. doi:10.1136/gutjnl-2013-305317 1951
Hepatology
whereas low circulating hepcidin levels—as they are found in
association with systemic iron deﬁciency—stimulate dietary iron
uptake and iron efﬂux from monocytes/macrophages making
the metal available for erythropoiesis.9 10 The regulation of hep-
cidin synthesis is thought to take place mainly at the transcrip-
tional level. Two main upstream signalling pathways regulate
hepcidin expression in the liver: the BMP6/SMAD1/5/8 and the
interleukin 6 (IL-6)/JAK2/STAT3 pathway, respectively.11–16
Interestingly, endoplasmic reticulum stress affects hepcidin tran-
scription in hepatocytes via activation of cyclic AMP response
element binding protein H (CREB-H) or GATA binding protein
4.17 18 The multitudinousness of factors impacting hepcidin
expression19 may be explained by the pivotal role of iron for
cell proliferation, cell metabolism and survival,6 20 and by the
key role of the metal in immunosurveillance and infection.21 22
Hypoxia has been shown to impact on iron homeostasis
mainly via hypoxia-inducible factor (HIF) regulation either via
direct transcriptional activation of iron metabolism genes or
indirectly via induction of EPO.23 24 Although HIFs have been
noticed to modulate iron homeostasis, the speciﬁc role of HIF
signalling on hepcidin expression has not been fully disen-
tangled so far.23 Moreover, in vitro studies using HepG2 and
HuH7 cells suggest that hypoxia results in generation of reactive
oxygen species and subsequent inhibition of C/EBPα and STAT3
mediated activation of the hepcidin promoter.25 26 Another
study performed with HuH7/THP1 cocultures indicates that the
interaction between monocytic cells and hepatocytes is necessary
to achieve hypoxia mediated hepcidin suppression.27 Moreover,
the BMP/SMAD4 responsive element of the hepcidin promoter
appears to be of importance for the transmission of hypoxia
mediated hepcidin regulation.13
So far, a few human studies have been published investigating
changes in circulating hepcidin levels during hypobaric
hypoxia.28–30 These studies provide interesting insights into
hypoxia mediated changes of iron metabolism, although mech-
anistic data toward the underlying pathways are lacking. Thus,
we performed a study with human volunteers who were chal-
lenged with exercise under normobaric hypoxic conditions and
combined this study with investigations in mouse models and
cell culture to identify the pathways being potentially respon-
sible for hypoxic regulation of iron homeostasis and hepcidin
expression, which led to the identiﬁcation of platelet derived
growth factor (PDGF)-BB as a novel regulator of hepatic hepci-
din expression and systemic iron homeostasis.
Design
Studies with human subjects
In all, 23 healthy volunteers participated in the study. Written
informed consent was obtained from all participants. The
studies were carried out in accordance with Helsinki guidelines
and approved by the ethical committee at the Medical
University of Innsbruck (approval number: AM2544, 239/4.12
and 273/5.7). Details of hypoxia studies and analysis of serum
parameters are described in online supplementary methods.
Animal care and in vivo mouse studies
C57BL/6 mice were purchased from Charles River Laboratories
(Germany); CREB-H knockout mice and corresponding wild-
type littermates were generated as previously described and
shipped to Innsbruck.17 We used male C57BL/6 mice at the age
of 6–8 weeks that were housed at the Animal Care Unit of the
Medical University Innsbruck under pathogen-free conditions
with ﬁxed day and night cycles and free access to water and
food. All animal experiments were performed in accordance
with the Austrian Animal Testing Act of 1988 and all experi-
ments were approved by the Austrian ethics committee
(BMWF-66.011/0073-II/3b/2011). Details of hypoxia studies
are shown in online supplementary methods.
Cell culture experiments
Primary murine hepatocytes were isolated from male
6–8-week-old C57BL/6 mice as previously reported.31 Primary
murine hepatocytes or human hepatocellular HepG2 cells were
used in all cell culture experiments (for details see online sup-
plementary methods).
RNA preparation, reverse transcription, RT-PCR
and western blotting
RNAwas extracted from adherent cells or tissue samples using a
guanidinium-isothiocyanate-phenol-chloroform-based protocol
as previously reported.32 Protein extraction and western blotting
were performed as detailed elsewhere.33 Further details are
given in online supplementary methods.
Statistical analysis
Statistical analyses were carried out using statistical analyses soft-
ware package (SPSS V.19.0). Following descriptive data evalu-
ation including tests for homoscedasticity and normal
distribution, we used analysis of variance (ANOVA) and post
hoc test or non-parametric Kruskal–Wallis and Mann–Whitney
U test, as appropriate. Bonferroni–Holmes correction was used
to correct for multiple testing. Correlations of two parameters
were tested with Pearson (parametric data) or Spearman-r (non-
parametric data) test.
RESULTS
Changes of circulating iron metabolism and inﬂammation
markers under normobaric, hypoxic conditions in healthy
human volunteers
The baseline characteristics and baseline laboratory variables of
healthy human volunteers are shown in table 1. As anticipated,
the exposure of subjects to hypoxia for 6 h resulted in a signiﬁ-
cant decrease of arterial oxygenation (pO2) and oxygen satur-
ation of the blood (SO2) (p<0.001, table 1 and ﬁgure 1A). We
measured several soluble factors and proteins which have been
described to be affected by hypoxia including EPO, soluble vas-
cular endothelial growth factor receptor (sVEGF-R), PDGF-BB,
IL-6, C reactive protein, tumour necrosis factor, transforming
growth factor β and serum hepcidin (ﬁgure 1 and table 1).1
Accordingly, the hypoxic challenge was accompanied by a sig-
niﬁcant increase in serum concentrations of sVEGF-R, EPO and
PDGF-BB, whereas hepcidin levels decreased signiﬁcantly
(p<0.001, table 1 and ﬁgure 1B,C). When evaluating the
impact of gender, we found no signiﬁcant differences with
regard to changes of hepcidin or PDGF-BB concentrations in
response to hypoxia (see online supplementary table S2).
Interestingly, exposure of participants to hypoxic conditions
resulted in a signiﬁcant increase of serum IL-6 levels (p<0.001)
within 6 h but not of other markers of inﬂammation investi-
gated herein.
Identiﬁcation of factors that mediate the hepcidin
response to hypoxia
As we observed a signiﬁcant reduction of serum hepcidin fol-
lowing hypoxic exposure, we performed correlation analysis to
identify factors being associated with alterations of hepcidin
levels (see online supplementary table S3). Hepcidin concentra-
tions signiﬁcantly correlated with serum iron and transferrin but
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